Didactics-Parametrial dissection in rad hyst_surgical QA and CERVENTES study_David Cibula

Parametrial dissection in rad hyst_surgical QA and CERVENTES study_David Cibula_Dec 2021.mp4

Video Transcription

Video Summary

The video discusses the risk factors and treatment options for cervical cancer. It highlights the controversy surrounding adjuvant treatment for patients with intermediate risk factors. The speaker discusses the ongoing trials that may lead to changes in treatment approaches, including the use of sentinel lymph nodes instead of pelvic lymphadenectomies and the consideration of definitive chemoradiation instead of radical surgery. The video also mentions the variation in criteria and definition for intermediate risk group patients and the evidence for adjuvant treatment coming from a trial conducted 30 years ago, which may not be acceptable by today's standards. The speaker emphasizes the importance of better patient selection and improved surgical techniques in achieving better outcomes. The video concludes with a discussion on the Cervantes trial, which aims to assess the need for adjuvant treatment in intermediate risk group patients. The trial design includes standardized surgery and the randomization of patients to receive adjuvant treatment or no adjuvant treatment, with different types of adjuvant treatment being considered. The video acknowledges the need for international support and outlines the timeline and follow-up required for the trial. Future meetings are suggested to further discuss the radicality of radical hysterectomy and the surgical quality assurance required for the study. No credits are mentioned in the video.

Keywords

cervical cancer

risk factors

treatment options

adjuvant treatment

intermediate risk factors